Skip to main content
Clinical Trials/NCT03416283
NCT03416283
Completed
Not Applicable

Remote Monitoring and Enhanced Social Support for Hypertension Management

University of Pennsylvania1 site in 1 country250 target enrollmentMay 20, 2018
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
University of Pennsylvania
Enrollment
250
Locations
1
Primary Endpoint
Systolic blood pressure
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

A 3-arm randomized pilot trial aimed at comparing the effectiveness of different remote approaches to improving blood pressure (BP) control.

Detailed Description

The investigators plan to leverage the Way to Health (WTH) platform to develop and evaluate a new HTN service-delivery model that is integrated with routine clinical care at Penn Family Care (PFC), an academic family medicine practice in West Philadelphia. Among patients with poorly controlled HTN: 1. The investigators will assess the effects of monitoring blood pressure and medication adherence with feedback to the patient and to the clinical practice, as needed if out of control. 2. The investigators will also compare the impact of providing feedback to a social support partner with facilitated cheerleading.

Registry
clinicaltrials.gov
Start Date
May 20, 2018
End Date
October 26, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Between 18 and 75 years old with HTN (ICD-10 code I10)
  • Has had at least two office visits at Penn Family Care (PFC) within the past 12 months (at time of chart review), with at least two of the visits with BP readings exceeding HTN guidelines, including the last visit (150/90 or 140/90 if ages 21-59 yrs with CKD or diabetes)
  • Must have a cellular phone with texting capabilities
  • Must be prescribed at least one medication for hypertension

Exclusion Criteria

  • Has metastatic (Stage IV) blood or solid tumor cancer
  • Has end stage renal disease
  • Has congestive heart failure
  • Has dementia
  • Has liver cirrhosis

Outcomes

Primary Outcomes

Systolic blood pressure

Time Frame: 4 months

Systolic blood pressure during the 4-month study visit, adjusted for initial systolic blood pressure

Secondary Outcomes

  • Percent of patients that are normotensive(4 months)
  • Medication adherence(4 months)
  • Diastolic blood pressure(4 months)

Study Sites (1)

Loading locations...

Similar Trials